Hipertensi PDF
Hipertensi PDF
Pendidikan :
S1 : FKUI 1992
Spesialis 1 : FKUI 2003
Spesialis 2 : KIPD/FKUI 2011
Fellow INASIM : PAPDI 2010
Fellow ACP : ACP, AS 2015
FELLOW ICA : ICA, 2015
Pekerjaan:
KETUA Divisi Kardiologi, Departemen Ilmu Penyakit Dalam FKUI-RSUPNCM 2014
Editor Acta Medica Indonesiana/Indonesian Journal of Internal Medicine
Organisasi:
WAKIL KETUA UMUM PB PAPDI 2015-sekarang
Wakil Ketua PAPDI Cabang Jakarta 2010- sekarang
Ketua I PB IKKI 2009-sekarang
CRE/062/Aug10-Aug11/MF
Peneliti dan Pengembangan:
Tim Karotis FKUI RSCUPNCM
Anggota Tim Stem Cell FKUI RSUPNCM
Tim Transplan Ginjal RSCM
Clinical Mentor
HIPERTENSI
Ika Prasetya W
Divisi Kardiologi,
Departemen Ilmu Penyakit Dalam
FKUI/RSCM
PDUI 2013
Outline
• Hipertensi
• Hipertensi pada Lansia
• Kombinasi terapi Hipertensi
• Hipertensi pada DM dan CKD
• Hipertensi dengan Gangguan Jantung
• Hipertensi pada Stroke
• Pencegahan Komplikasi
• Krisis Hipertensi
• Hipertensi pada Kehamilan
Hipertensi
Kasus 1:
Laki-laki, 32 tahun, tanpa keluhan, datang
karena dikatakan menderita tekanan darah
tinggi saat menjalani “medical check up”.
TD 150/100 mmHg, pada pemeriksaan fisik tidak
ditemukan kelainan, foto torak tidak ada
pembesaran jantung, EKG saat “check up” tak
ada kelainan
Pertanyaan:
1. Masalah pasien?
2. Tatalaksana yang akan diberikan?
3. Pemeriksaan apa yang sebaiknya dikerjakan?
Blood Pressure Classification
BP Classification SBP mmHg DBP mmHg
Each increment of 20/10 mmHg doubles the risk of CVD across the
entire BP range starting from 115/75 mmHg.
4
4X
risk
2
2X
1X risk risk
0
115/75 135/85 155/95 175/105
Systolic BP/Diastolic BP (mmHg)
*** **
***
***
‘Older’ patients (mean >65 years)
***
and…….
–60 ‘Younger’ patients (<65 years)
* p<0 .05; ** p<0.01; *** p<0.00 1
–80
Not at Goal
Blood Pressure
40 Systolic Pressure
30 mmHg
20
10
5 year 0
<120 120-139 140-159 160-179 180-199 >200
survival 50
40
Diastolic Pressure
30 mmHg
20
10
0
<70 70-79 80-89 90-99 100-109 >110
Hypertension in the Very Elderly Trial (HYVET)
Baseline 3 mo 6 mo
Hypertension in the Elderly
Not at Goal
Blood Pressure
Angiotensin
b-blockers receptor blockers
(ARBs)
Calcium channel
a-blockers
blockers (CCBs)
• ACE-I or ARB
• Lifestyle ’s
• If BP ≥ 150/90:
- ACE-I or ARB Diuretic (or CCB?)
BP ≥ 130/80 after 1 mo
Add Diuretic
• Thiazide for most patients
• Loop diuretic if eGFR < 30-50 (Cr ≥ 1.6-1.9 mg%)
- BID furosemide, bumetanide or QD torsemide
Am J Kid Dis 2007; 49(Suppl 2):S74 Diabetes Care 2007; 30(Suppl 1):S4
PHARM-RX OF HTN IN DIABETES: II
ACE-I or ARB Diuretic
BP ≥ 130/80 after 1 mo
BP ≥ 130/80 after 1 mo
BP ≥ 130/80 after 1 mo
Consultation
Am J Kid Dis 2007; 49(Suppl 2):S74 Diabetes Care 2007; 30(Suppl 1):S4
RENOPROTECTION IN DIABETES
Normoalbuminuria (ACR < 30)
Θ
Type 2 DM: ACE-I BENEDICT:
49% vs verapamil
20
10
0
Mild Moderate Severe EF<50% EF<40%
Diastolic Dysfunction Systolic Dysfunction
Sources: Unpublished data for 1999–2000 computed by M. Wolz, National Heart, Lung, and Blood Institute; JNC 6.
Laboratory Tests
Routine Tests
• Electrocardiogram
• Urinalysis
• Blood glucose, and hematocrit
• Serum potassium, creatinine, or the corresponding estimated GFR,
and calcium
• Lipid profile, after 9- to 12-hour fast, that includes high-density and
low-density lipoprotein cholesterol, and triglycerides
Optional tests
• Measurement of urinary albumin excretion or albumin/creatinine ratio
More extensive testing for identifiable causes is not generally indicated
unless BP control is not achieved
When a Patient is Still Not at Goal?
• Optimize dosages or add additional drugs until
goal blood pressure is achieved
• What do you do when you are using several
effective medications?
– Consider causes of resistant hypertension
– Assure drug therapy is rational
– “Tricks of the trade”
Identifiable Causes of Hypertension
Sleep apnea
Drug-induced or related causes
Chronic kidney disease
Primary aldosteronism
Renovascular disease
Chronic steroid therapy and Cushing’s syndrome
Pheochromocytoma
Coarctation of the aorta
Thyroid or parathyroid disease
Weeks
Grading of
Recommendations
• Grade A – Very strong evidence
• Grade B – Fair evidence
• Grade C – Poor studies
• Grade D – Expert opinion
Back to the Case
• She remains asymptomatic and states there are good
fetal movements
• Exam shows her to be overweight
• BP is 155/98
• No pitting edema, reflexes are brisk, but no clonus
• There is no evidence of any secondary cause of HTN
• Urinary dipstick is negative for protein
Appropriate measures at this point include:
A) Laboratory investigations
B) 24 hour urine collection for protein
C) Admission to hospital
D) All of the above
E) A and B
Definitions
• HTN defined as DBP > 90 mm Hg (D)
• Severe HTN is > 110 mm Hg (D)
• All reading > 90 mm Hg must be confirmed 4
hours later with 2nd reading (D)
– Except when > 110 mm Hg
• Significant proteinuria defined as > 0.3 g/day
using a 24 hr urine collection (increased from 0.15
g/day in non-pregnancy) (A)
• Severe proteinuria is > 3 g/day
• Edema and weight gain no longer used to
diagnosis of PET
Classification of Hypertensive Disorders in
Pregnancy
CHS classification Interpretation
•
90 mm
Third line drugs:
Hg (grade D)
– Hydralazine + clonidine (A)
– Hydralazine + metoprolol (A)
– Clonidine (B)
No good data
Outcomes of treatment
IUGR
Poor evidence
?Maybe Beta blockers cause IUGR?
?Maybe Diuretics cause IUGR?
What about Non-Parmacologic
Treatment and Prevention?
Indicated for SBP> 140mmHg or DBP >
90mmHg
“Non-pharmacologic Rx alone is
recommended for women with SBP of 140-
150 mmHg or DBP 90-99mmHg in the absence
of maternal or fetal risk factors (Grade D)”
Possibly Promising therapies
ASA
no role for routine use (Grade B)
BUT…low dose ASA reduces incidence of pre-term
delivery and early onset PET in women at risk
(Grade A)
Calcium
primary prevention of PET
does not prevent development of more severe
GESTATIONAL HTN (Grade B) (NEJM 1991, NEJM
1997)
Others...
Bedrest
no evidence for efficacy
in fact, Grade B evidence that it is not advisable
Exercise
no evidence
Stress control
no evidence
Increased energy and protein intake
Grade B evidence that they are NOT beneficial
Weight reduction
not recommended (Grade C)
Na restriction
not recommended (Grade C)
Alcohol restriction
no evidence
Magnesium
not justified (Grade B)
Zinc/iron/folate
not beneficial (Grade B)
Back to the Case
• Methyldopa, 250 mg BID is started
• BP drops to 140/88
• Pt. Discharged home
A) Labetalol 5-10 mg IV
B) Nifedipine 5 mg PO
C) Metoprolol 50 mg PO
D) Hydralazine 5-10 mg IV
Management of Severe Hypertension in Pregnancy
(DBP> 110 mm Hg)
• First line drugs:
– Hydralazine (grade B)
– Labetalol (grade B)
– Nifedipine (grade B)
Treatment goal: 90-100 mm Hg
• Second line drugs: if refractory to above
– Diazoxide (grade D)
– Sodium nitroprusside (grade D)
Clinical Laboratory
• headache • proteinuria >0.3 g/24 hr
• vision disturbances • high uric acid (indicates
• RUQ pain
severity)
• nausea and vomiting
• elevated blood pressure • HELLP syndrome
• edema - hemolysis, high liver enzymes,
• convulsions
low platelets
• stroke
• increased hematocrit
• cerebral edema
• pulmonary edema • elevated PTT, d-Dimers, low
• retinal detachment fibrinogen (markers of DIC)
Back to the Case
• She is treated with labetalol 10 mg IV
• BP drops to 160/97
• Fetal heart tracing is reassuring
• Lab tests are as follows: AST 520, ALT 480, platelets
200, creatinine 100, uric acid 500
• She is transferred to labour and delivery, and has a
tonic-clonic seizure
Which of the following is the MOST EFFECTIVE in
preventing further seizures?
A) Dilantin
B) Diazepam
C) Magnesium sulfate
D) Control of blood pressure
Eclampsia
• MgSO4 better
Should MgSO4 have been initiated
before the seizure?
Probably…
MAGPIE trial
• Primary prevention of eclampsia for all
degrees of PET
• NNT = 63 in severe PET
• NNT = 109 in mild-moderate PET
Back to the Case
• patient is treated with MgSO4
• BP controlled with labetalol IV
• She undergoes a STAT caesarean section and delivers
a healthy baby boy (taken to NICU…doing well)
• After 24 hrs of monitoring, she is transferred to the
ward, and discharged 6 days later
GOAL : IDENTIFICATION OF SECONDARY (IDENTIFIABLE)
CAUSES OF HYPERTENSION
SUSPECTED DIAGNOSIS CLINICAL FEATURES DIAGNOSTIC TESTING
MRI, aortogram
Coarctation of the Arm pulses >leg pulses, arm BP >leg BP, chest
aorta bruits, rib notching on chest radiograph